NEW YORK, Nov. 8 – Sequenom said Thursday it received a $2.2 million grant from the National Institutes of Health to conduct a genome-wide disease association study.

Sequenom of San Diego said it will use its MassArray technology and 100,000 SNP assays to look for genetic variations among people with the blood disease beta-thalassemia.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.